用COMT和Neuregulin 1标记物来个性化治疗使用Risperidone单疗法治疗的精神分裂症谱系障碍
Mariana Bondrescu1,2,3, Liana Dehelean1,2, Simona Sorina Farcas4
1Department of Neurosciences-Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Biomolecules
|July 27, 2024
概括
在COMT和NRG1中的遗传变异影响了对精神病的RISPERIDONE治疗反应. 特定的COMT rs4680和NRG1多态性影响精神分裂症谱系障碍的症状改善和剂量.
科学领域:
- 药物遗传学 药物遗传学
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 对精神病的个性化治疗越来越依赖于药物遗传标记.
- 有限的数据存在于Catechol-O-methyltransferase (COMT) 和Neuregulin 1 (NRG1) 多态体对RISPERIDONE疗效的影响.
研究的目的:
- 研究COMT rs4680和NRG1 (rs35753505,rs3924999) 多态体对精神分裂症谱系障碍 (SSD) 患者里斯比里治疗反应的影响.
主要方法:
- 使用RT-PCR对接受Risperidone单一治疗的103名SSD患者进行了COMT rs4680,NRG1 rs35753505和rs3924999的基因定型.
- 在基线和六周治疗后,使用阳性和阴性综合征量表 (PANSS) 评估症状严重程度.
主要成果:
- 在COMT rs4680基因型中,在入院PANSS中显示出显著的差异,负分数 (AG>AA,p=0.03).
- 在治疗后,PANSS 总体改善因COMT rs4680基因型 (AA>GG,p=0.05) 和总得分 (AA>AG,p=0.04;AA>GG,p=0.02) 而有所不同.
- NRG1 rs35753505 (CC>CT,p=0.02) 和rs3924999 (GG
结论:
- COMT rs4680和NRG1 rs35753505,rs3924999的多态性显著影响SSD患者的RISPERIDONE治疗反应.
- 这些发现支持了特定遗传标记在定制抗精神病治疗以改善患者结果中的作用.
- 需要进一步的研究来验证这些药物遗传学关联在更大的队列中.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications


